Cash & equivalents increased 873.7%
Cash & equivalents changed +873.7% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +873.7% from the comparable as-filed period.
Gross margin changed -998 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Gross profit changed +984.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Inventory changed +365.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Net income changed -722.2% from the comparable as-filed period.
Operating income changed -1661.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed -4708 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Research & development changed +630.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Revenue changed +1235.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.